AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2014
Jul 15, 2014
32566_dirs_2014-07-15_ad3583d6-c8ab-47a7-b118-d3c3bcd44476.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2014-07-14
Reporting Person: LANCHBURY JERRY S (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-14 | Common Stock | M | 20000.0 | $18.06 | Acquired | 34551 | Direct |
| 2014-07-14 | Common Stock | S | 20000.0 | $39.8541 | Disposed | 14551 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-07-14 | Non-Qualified Stock Option (right to buy) | $18.06 | M | 20000.0 | Disposed | 2017-09-26 | Common Stock (20000) | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2